Cargando…
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines
The Coronavirus Disease 2019 (COVID-19) pandemic has had a devastating impact on global health, and has resulted in an unprecedented, international collaborative effort to develop vaccines to control the outbreak, protect human lives, and avoid further social and economic disruption. Mass vaccinatio...
Autores principales: | Gubernot, Diane, Jazwa, Amelia, Niu, Manette, Baumblatt, Jane, Gee, Julianne, Moro, Pedro, Duffy, Jonathan, Harrington, Theresa, McNeil, Michael M., Broder, Karen, Su, John, Kamidani, Satoshi, Olson, Christine K., Panagiotakopoulos, Lakshmi, Shimabukuro, Tom, Forshee, Richard, Anderson, Steven, Bennett, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118666/ https://www.ncbi.nlm.nih.gov/pubmed/34088506 http://dx.doi.org/10.1016/j.vaccine.2021.05.016 |
Ejemplares similares
-
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
por: Hause, Anne M., et al.
Publicado: (2021) -
1077 Adverse events following measles, mumps, and rubella (MMR) vaccine in adults reported to the Vaccine Adverse Event Reporting System, 2003-2013
por: Sukumaran, Lakshmi, et al.
Publicado: (2014) -
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for
Admission and Pregnancy Characteristics — Eight U.S. Health Care Centers,
March 1–May 30, 2020
por: Panagiotakopoulos, Lakshmi, et al.
Publicado: (2020) -
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
por: Hause, Anne M., et al.
Publicado: (2022) -
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)